Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Medical Grade Silicone Market

ID: MRFR/CnM/15413-HCR
111 Pages
Chitranshi Jaiswal
Last Updated: April 06, 2026

US Medical Grade Silicone Market Research Report By Product (Elastomers, Gels, Medical Adhesives, Medical Coatings, Others) and By Application (Medical Devices, Medical Tapes, Orthopedics, Prosthetics, Contact Lenses) - Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Medical Grade Silicone Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Application (USD Million)
  49.     4.1.1 Medical Devices
  50.     4.1.2 Surgical Instruments
  51.     4.1.3 Prosthetics
  52.     4.1.4 Drug Delivery Systems
  53.     4.1.5 Wound Care
  54.   4.2 Chemicals and Materials, BY End Use (USD Million)
  55.     4.2.1 Hospitals
  56.     4.2.2 Clinics
  57.     4.2.3 Home Healthcare
  58.     4.2.4 Research Laboratories
  59.     4.2.5 Pharmaceutical Companies
  60.   4.3 Chemicals and Materials, BY Type (USD Million)
  61.     4.3.1 Liquid Silicone Rubber
  62.     4.3.2 Solid Silicone Rubber
  63.     4.3.3 Silicone Gels
  64.     4.3.4 Silicone Adhesives
  65.     4.3.5 Silicone Coatings
  66.   4.4 Chemicals and Materials, BY Formulation (USD Million)
  67.     4.4.1 Platinum-Cured Silicone
  68.     4.4.2 Peroxide-Cured Silicone
  69.     4.4.3 Thermoplastic Silicone
  70.     4.4.4 High-Temperature Silicone
  71.     4.4.5 Low-Temperature Silicone
  72.   4.5 Chemicals and Materials, BY Regulatory Compliance (USD Million)
  73.     4.5.1 FDA Approved
  74.     4.5.2 ISO Certified
  75.     4.5.3 Biocompatibility Standards
  76.     4.5.4 USP Class VI Compliance
  77.     4.5.5 REACH Compliance
  78. 5 SECTION V: COMPETITIVE ANALYSIS
  79.   5.1 Competitive Landscape
  80.     5.1.1 Overview
  81.     5.1.2 Competitive Analysis
  82.     5.1.3 Market share Analysis
  83.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  84.     5.1.5 Competitive Benchmarking
  85.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  86.     5.1.7 Key developments and growth strategies
  87.       5.1.7.1 New Product Launch/Service Deployment
  88.       5.1.7.2 Merger & Acquisitions
  89.       5.1.7.3 Joint Ventures
  90.     5.1.8 Major Players Financial Matrix
  91.       5.1.8.1 Sales and Operating Income
  92.       5.1.8.2 Major Players R&D Expenditure. 2023
  93.   5.2 Company Profiles
  94.     5.2.1 Dow Corning (US)
  95.       5.2.1.1 Financial Overview
  96.       5.2.1.2 Products Offered
  97.       5.2.1.3 Key Developments
  98.       5.2.1.4 SWOT Analysis
  99.       5.2.1.5 Key Strategies
  100.     5.2.2 Wacker Chemie AG (DE)
  101.       5.2.2.1 Financial Overview
  102.       5.2.2.2 Products Offered
  103.       5.2.2.3 Key Developments
  104.       5.2.2.4 SWOT Analysis
  105.       5.2.2.5 Key Strategies
  106.     5.2.3 Momentive Performance Materials (US)
  107.       5.2.3.1 Financial Overview
  108.       5.2.3.2 Products Offered
  109.       5.2.3.3 Key Developments
  110.       5.2.3.4 SWOT Analysis
  111.       5.2.3.5 Key Strategies
  112.     5.2.4 Elkem ASA (NO)
  113.       5.2.4.1 Financial Overview
  114.       5.2.4.2 Products Offered
  115.       5.2.4.3 Key Developments
  116.       5.2.4.4 SWOT Analysis
  117.       5.2.4.5 Key Strategies
  118.     5.2.5 Shin-Etsu Chemical (JP)
  119.       5.2.5.1 Financial Overview
  120.       5.2.5.2 Products Offered
  121.       5.2.5.3 Key Developments
  122.       5.2.5.4 SWOT Analysis
  123.       5.2.5.5 Key Strategies
  124.     5.2.6 KCC Corporation (KR)
  125.       5.2.6.1 Financial Overview
  126.       5.2.6.2 Products Offered
  127.       5.2.6.3 Key Developments
  128.       5.2.6.4 SWOT Analysis
  129.       5.2.6.5 Key Strategies
  130.     5.2.7 NuSil Technology (US)
  131.       5.2.7.1 Financial Overview
  132.       5.2.7.2 Products Offered
  133.       5.2.7.3 Key Developments
  134.       5.2.7.4 SWOT Analysis
  135.       5.2.7.5 Key Strategies
  136.     5.2.8 Med silicone (US)
  137.       5.2.8.1 Financial Overview
  138.       5.2.8.2 Products Offered
  139.       5.2.8.3 Key Developments
  140.       5.2.8.4 SWOT Analysis
  141.       5.2.8.5 Key Strategies
  142.     5.2.9 Reiss Manufacturing (US)
  143.       5.2.9.1 Financial Overview
  144.       5.2.9.2 Products Offered
  145.       5.2.9.3 Key Developments
  146.       5.2.9.4 SWOT Analysis
  147.       5.2.9.5 Key Strategies
  148.   5.3 Appendix
  149.     5.3.1 References
  150.     5.3.2 Related Reports
  151. 6 LIST OF FIGURES
  152.   6.1 MARKET SYNOPSIS
  153.   6.2 US MARKET ANALYSIS BY APPLICATION
  154.   6.3 US MARKET ANALYSIS BY END USE
  155.   6.4 US MARKET ANALYSIS BY TYPE
  156.   6.5 US MARKET ANALYSIS BY FORMULATION
  157.   6.6 US MARKET ANALYSIS BY REGULATORY COMPLIANCE
  158.   6.7 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  159.   6.8 RESEARCH PROCESS OF MRFR
  160.   6.9 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  161.   6.10 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  162.   6.11 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  163.   6.12 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  164.   6.13 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
  165.   6.14 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
  166.   6.15 CHEMICALS AND MATERIALS, BY END USE, 2024 (% SHARE)
  167.   6.16 CHEMICALS AND MATERIALS, BY END USE, 2024 TO 2035 (USD Million)
  168.   6.17 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
  169.   6.18 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
  170.   6.19 CHEMICALS AND MATERIALS, BY FORMULATION, 2024 (% SHARE)
  171.   6.20 CHEMICALS AND MATERIALS, BY FORMULATION, 2024 TO 2035 (USD Million)
  172.   6.21 CHEMICALS AND MATERIALS, BY REGULATORY COMPLIANCE, 2024 (% SHARE)
  173.   6.22 CHEMICALS AND MATERIALS, BY REGULATORY COMPLIANCE, 2024 TO 2035 (USD Million)
  174.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  175. 7 LIST OF TABLES
  176.   7.1 LIST OF ASSUMPTIONS
  177.     7.1.1
  178.   7.2 US MARKET SIZE ESTIMATES; FORECAST
  179.     7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  180.     7.2.2 BY END USE, 2025-2035 (USD Million)
  181.     7.2.3 BY TYPE, 2025-2035 (USD Million)
  182.     7.2.4 BY FORMULATION, 2025-2035 (USD Million)
  183.     7.2.5 BY REGULATORY COMPLIANCE, 2025-2035 (USD Million)
  184.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  185.     7.3.1
  186.   7.4 ACQUISITION/PARTNERSHIP
  187.     7.4.1

US Chemicals and Materials Market Segmentation

Chemicals and Materials By Application (USD Million, 2025-2035)

  • Medical Devices
  • Surgical Instruments
  • Prosthetics
  • Drug Delivery Systems
  • Wound Care

Chemicals and Materials By End Use (USD Million, 2025-2035)

  • Hospitals
  • Clinics
  • Home Healthcare
  • Research Laboratories
  • Pharmaceutical Companies

Chemicals and Materials By Type (USD Million, 2025-2035)

  • Liquid Silicone Rubber
  • Solid Silicone Rubber
  • Silicone Gels
  • Silicone Adhesives
  • Silicone Coatings

Chemicals and Materials By Formulation (USD Million, 2025-2035)

  • Platinum-Cured Silicone
  • Peroxide-Cured Silicone
  • Thermoplastic Silicone
  • High-Temperature Silicone
  • Low-Temperature Silicone

Chemicals and Materials By Regulatory Compliance (USD Million, 2025-2035)

  • FDA Approved
  • ISO Certified
  • Biocompatibility Standards
  • USP Class VI Compliance
  • REACH Compliance

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions